AnnJi Advances AJ201 into Phase 3 Trial for Kennedy’s Disease
AJ201 (rosolutamide) moves into the pivotal Phase 3 ROMA-KD trial for Kennedy disease, or SBMA. Mechanism, earlier data and what is unknown.
AJ201 (rosolutamide) moves into the pivotal Phase 3 ROMA-KD trial for Kennedy disease, or SBMA. Mechanism, earlier data and what is unknown.